Darya-Varia Laboratoria Tbk (DVLA) - Net Assets

Latest as of June 2025: Rp1.49 Trillion IDR ≈ $87.49 Million USD

Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has net assets worth Rp1.49 Trillion IDR (≈ $87.49 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp2.40 Trillion ≈ $140.52 Million USD) and total liabilities (Rp904.97 Billion ≈ $53.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DVLA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp1.49 Trillion
% of Total Assets	62.26%
Annual Growth Rate	9.33%
5-Year Change	9.25%
10-Year Change	48.84%
Growth Volatility	8.91

Darya-Varia Laboratoria Tbk - Net Assets Trend (2000–2024)

This chart illustrates how Darya-Varia Laboratoria Tbk's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Darya-Varia Laboratoria Tbk for the complete picture of this company's asset base.

Annual Net Assets for Darya-Varia Laboratoria Tbk (2000–2024)

The table below shows the annual net assets of Darya-Varia Laboratoria Tbk from 2000 to 2024. For live valuation and market cap data, see market cap of Darya-Varia Laboratoria Tbk.

Year	Net Assets	Change
2024-12-31	Rp1.45 Trillion ≈ $84.90 Million	+3.17%
2023-12-31	Rp1.40 Trillion ≈ $82.29 Million	+0.06%
2022-12-31	Rp1.40 Trillion ≈ $82.25 Million	+1.65%
2021-12-31	Rp1.38 Trillion ≈ $80.91 Million	+4.11%
2020-12-31	Rp1.33 Trillion ≈ $77.72 Million	+1.55%
2019-12-31	Rp1.31 Trillion ≈ $76.53 Million	+8.82%
2018-12-31	Rp1.20 Trillion ≈ $70.33 Million	+7.52%
2017-12-31	Rp1.12 Trillion ≈ $65.41 Million	+3.40%
2016-12-31	Rp1.08 Trillion ≈ $63.26 Million	+10.89%
2015-12-31	Rp973.52 Billion ≈ $57.04 Million	+1.15%
2014-12-31	Rp962.43 Billion ≈ $56.39 Million	+5.22%
2013-12-31	Rp914.70 Billion ≈ $53.60 Million	+8.69%
2012-12-31	Rp841.55 Billion ≈ $49.31 Million	+15.61%
2011-12-31	Rp727.92 Billion ≈ $42.65 Million	+13.63%
2010-12-31	Rp640.60 Billion ≈ $37.54 Million	+15.44%
2009-12-31	Rp554.92 Billion ≈ $32.52 Million	+9.27%
2008-12-31	Rp507.85 Billion ≈ $29.76 Million	+9.87%
2007-12-31	Rp462.23 Billion ≈ $27.08 Million	+12.11%
2006-12-31	Rp412.31 Billion ≈ $24.16 Million	+5.56%
2005-12-31	Rp390.60 Billion ≈ $22.89 Million	+22.44%
2004-12-31	Rp319.03 Billion ≈ $18.69 Million	+16.65%
2003-12-31	Rp273.48 Billion ≈ $16.02 Million	+20.43%
2002-12-31	Rp227.09 Billion ≈ $13.31 Million	+38.84%
2001-12-31	Rp163.55 Billion ≈ $9.58 Million	-3.89%
2000-12-31	Rp170.17 Billion ≈ $9.97 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Darya-Varia Laboratoria Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 110927585700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Rp1.11 Trillion	76.56%
Common Stock	Rp280.00 Billion	19.32%
Other Comprehensive Income	Rp-18.58 Billion	-1.28%
Other Components	Rp78.27 Billion	5.40%
Total Equity	Rp1.45 Trillion	100.00%

Darya-Varia Laboratoria Tbk Competitors by Market Cap

The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their market capitalization.

Company	Market Cap
Hanil Feed Co. Ltd KQ:005860	$105.34 Million
Hurriyet Gazetecilik ve Matbaacilik AS IS:HURGZ	$105.41 Million
Americas Car-Mart Inc NASDAQ:CRMT	$105.43 Million
Frontier Energy Ltd AU:FHE	$105.48 Million
Netfonds AG XETRA:NF4	$105.32 Million
Geodrill Ltd F:7GD	$105.31 Million
AleAnna, Inc. Class A Common Stock NASDAQ:ANNA	$105.31 Million
Clarus Corp NASDAQ:CLAR	$105.22 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Darya-Varia Laboratoria Tbk's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 1,404,432,093,000 to 1,448,971,508,000, a change of 44,539,415,000 (3.2%).
Net income of 156,147,303,000 contributed positively to equity growth.
Dividend payments of 120,960,000,000 reduced retained earnings.
Other comprehensive income increased equity by 9,352,112,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp156.15 Billion	+10.78%
Dividends Paid	Rp120.96 Billion	-8.35%
Other Comprehensive Income	Rp9.35 Billion	+0.65%
Total Change	Rp-	3.17%

Book Value vs Market Value Analysis

This analysis compares Darya-Varia Laboratoria Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.24x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 3.24x to 1.24x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-12-31	Rp495.47	Rp1605.00	x
2010-12-31	Rp571.97	Rp1605.00	x
2011-12-31	Rp649.93	Rp1605.00	x
2012-12-31	Rp751.38	Rp1605.00	x
2013-12-31	Rp816.70	Rp1605.00	x
2014-12-31	Rp862.45	Rp1605.00	x
2015-12-31	Rp872.39	Rp1605.00	x
2016-12-31	Rp967.43	Rp1605.00	x
2017-12-31	Rp1000.34	Rp1605.00	x
2018-12-31	Rp1075.56	Rp1605.00	x
2019-12-31	Rp1167.44	Rp1605.00	x
2020-12-31	Rp1184.18	Rp1605.00	x
2021-12-31	Rp1242.33	Rp1605.00	x
2022-12-31	Rp1253.23	Rp1605.00	x
2023-12-31	Rp1253.96	Rp1605.00	x
2024-12-31	Rp1293.72	Rp1605.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Darya-Varia Laboratoria Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.78%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.48%
• Asset Turnover: 0.97x
• Equity Multiplier: 1.49x
Recent ROE (10.78%) is below the historical average (14.40%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	27.98%	11.57%	1.70x	1.42x	Rp40.82 Billion
2003	16.96%	11.89%	1.04x	1.37x	Rp19.05 Billion
2004	15.61%	11.67%	0.99x	1.35x	Rp17.91 Billion
2005	18.32%	13.24%	0.98x	1.41x	Rp32.52 Billion
2006	12.74%	9.11%	1.03x	1.35x	Rp11.28 Billion
2007	10.80%	9.80%	0.91x	1.21x	Rp3.69 Billion
2008	13.94%	12.26%	0.91x	1.26x	Rp20.03 Billion
2009	13.02%	8.32%	1.11x	1.41x	Rp16.78 Billion
2010	17.31%	11.93%	1.09x	1.33x	Rp46.82 Billion
2011	16.61%	12.44%	1.05x	1.28x	Rp48.12 Billion
2012	17.69%	13.69%	1.01x	1.28x	Rp64.75 Billion
2013	13.75%	11.42%	0.93x	1.30x	Rp34.33 Billion
2014	8.41%	7.33%	0.89x	1.28x	Rp-15.31 Billion
2015	11.08%	8.26%	0.95x	1.41x	Rp10.54 Billion
2016	14.09%	10.48%	0.95x	1.42x	Rp44.13 Billion
2017	14.53%	10.30%	0.96x	1.47x	Rp50.62 Billion
2018	16.72%	11.81%	1.01x	1.40x	Rp80.63 Billion
2019	16.98%	12.23%	0.99x	1.40x	Rp91.18 Billion
2020	12.22%	8.86%	0.92x	1.50x	Rp29.44 Billion
2021	10.53%	7.71%	0.91x	1.50x	Rp7.36 Billion
2022	10.64%	7.79%	0.95x	1.43x	Rp9.01 Billion
2023	10.42%	7.74%	0.93x	1.45x	Rp5.89 Billion
2024	10.78%	7.48%	0.97x	1.49x	Rp11.25 Billion

Industry Comparison

This section compares Darya-Varia Laboratoria Tbk's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $672,055,504,148
Average return on equity (ROE) among peers: 48.35%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Darya-Varia Laboratoria Tbk (DVLA)	Rp1.49 Trillion	27.98%	0.61x	$105.33 Million
Indofarma Tbk (INAF)	$298.72 Billion	0.71%	1.44x	$22.88 Million
Merck Tbk (MERK)	$518.28 Billion	224.46%	1.44x	$110.25 Million
Phapros Tbk PT (PEHA)	$740.98 Billion	1.49%	1.48x	$14.67 Million
Pyridam Farma Tbk (PYFA)	$62.14 Billion	2.30%	0.13x	$198.84 Million
Sido Muncul PT (SIDO)	$1.30 Trillion	29.70%	0.65x	$862.39 Million
Tempo Scan Pacific Tbk (TSPC)	$1.11 Trillion	31.40%	0.29x	$644.79 Million

About Darya-Varia Laboratoria Tbk

JK:DVLA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$105.33 Million

Rp1.80 Trillion IDR

Market Cap Rank

#18980 Global

#333 in Indonesia

Share Price

Rp1605.00

Change (1 day)

+0.00%

52-Week Range

Rp1580.00 - Rp1710.00

All Time High

Rp2534.71